Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-04-04

Clinical Trial Update: pBFS-guided Dual-target cTBS for Aphasia After Stroke [NA]

View source ↗

Summary

A new clinical trial sponsored by Changping Laboratory is recruiting to test pBFS-guided dual-target cTBS for aphasia following stroke.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Changping Laboratory | Conditions: Stroke, Aphasia | NA | Status: RECRUITING